alendronate has been researched along with Atherogenesis in 6 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "40 rats were randomly divided into 4 groups: control, untreated atherosclerosis group, atherosclerotic rats treated with carvedilol (10mg/kg/d) and atherosclerotic rats treated with alendronate sodium (10mg/kg/d)." | 4.02 | Matrix metalloproteinase 9 a potential major player connecting atherosclerosis and osteoporosis in high fat diet fed rats. ( Abdelgwad, M; Estaphan, S; Kamar, S; Mostafa, S; Rashed, L; Sabry, M, 2021) |
| "Osteoporosis and atherosclerosis are the two most common diseases in postmenopausal women." | 2.79 | Change in arterial stiffness associated with monthly bisphosphonate treatment in women with postmenopausal osteoporosis. ( Igase, M; Kohara, K; Miki, T; Ochi, M; Ohara, M; Okada, Y; Tabara, Y; Takita, R, 2014) |
| " However, an inverse dose-response relationship was seen, with an increased risk in those with low adherence (≤0." | 1.38 | Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones? ( Vestergaard, P, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sabry, M | 1 |
| Mostafa, S | 1 |
| Rashed, L | 1 |
| Abdelgwad, M | 1 |
| Kamar, S | 1 |
| Estaphan, S | 1 |
| Igase, M | 1 |
| Kohara, K | 1 |
| Tabara, Y | 1 |
| Ohara, M | 1 |
| Takita, R | 1 |
| Ochi, M | 1 |
| Okada, Y | 1 |
| Miki, T | 1 |
| Mohamed, MT | 1 |
| Abuelezz, SA | 1 |
| Atalla, SS | 1 |
| El Aziz, LFA | 1 |
| Gorge, SS | 1 |
| Strandberg, TE | 1 |
| Vestergaard, P | 1 |
| Yamada, S | 1 |
| Inaba, M | 1 |
| Nishizawa, Y | 1 |
1 review available for alendronate and Atherogenesis
| Article | Year |
|---|---|
[Influence on atherosclerosis of improvement of bone mineral density after medication for osteoporosis].
Topics: Alendronate; Apolipoprotein A-I; Arthritis, Rheumatoid; Atherosclerosis; Bone and Bones; Bone Densit | 2007 |
1 trial available for alendronate and Atherogenesis
| Article | Year |
|---|---|
Change in arterial stiffness associated with monthly bisphosphonate treatment in women with postmenopausal osteoporosis.
Topics: Administration, Oral; Aged; Alendronate; Ankle Brachial Index; Atherosclerosis; Bone Density Conserv | 2014 |
4 other studies available for alendronate and Atherogenesis
| Article | Year |
|---|---|
Matrix metalloproteinase 9 a potential major player connecting atherosclerosis and osteoporosis in high fat diet fed rats.
Topics: Alendronate; Alkaline Phosphatase; Animals; Atherosclerosis; Biomarkers; Bone Density; Bone Remodeli | 2021 |
The anti-osteoporotic and anti-atherogenic effects of alendronate and simvastatin in ovariectomized rats fed high fat diet: A comparative study of combination therapy versus monotherapy.
Topics: Alendronate; Alkaline Phosphatase; Animals; Atherosclerosis; Body Weight; Bone and Bones; Bone Densi | 2017 |
Alendronate, osteoporosis, and atherosclerosis.
Topics: Alendronate; Atherosclerosis; Atrial Fibrillation; Bone Density Conservation Agents; Humans; Osteopo | 2008 |
Acute myocardial infarction and atherosclerosis of the coronary arteries in patients treated with drugs against osteoporosis: calcium in the vessels and not the bones?
Topics: Aged; Alendronate; Atherosclerosis; Bone Density Conservation Agents; Calcium; Cohort Studies; Dipho | 2012 |